RASHA BAHRI: Open Payments
NPI 1598495574 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 22 payments from 9 companies in 2025. Trend: 2023 $1,292 · 2024 $350 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| Agios Pharmaceuticals, Inc. | 3 | $178 |
| Ardelyx, Inc. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Novo Nordisk Inc | 4 | $79 |
| Exact Sciences Corporation | 3 | $44 |
| ABBVIE INC. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
Products named: PYRUKYND, IBSRELA, CAPLYTA, Cologuard Collection Kit, Wegovy, Rybelsus, SKYRIZI, GEMTESA.
Industry payments across MI — which companies pay providers there.
